(Q46638446)

English

Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure

scientific article published on 5 August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

author name string

Deddo Moertl

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

Rudolf Berger

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

Martin Huelsmann

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

Anja Bojic

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

Richard Pacher

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

publication date

5 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

1156-1163

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Mechanism of the positive inotropic effect of milrinone in cultured embryonic chick ventricular cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Myocardial efficiency during levosimendan infusion in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Effect of long-term oral pretreatment with levosimendan on cardiac arrhythmias during coronary artery occlusion in conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Revascularization of myocardial scar tissue following prostaglandin E1-therapy in patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Recognition and management of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.05.001

21 January 2018

Identifiers

10.1016/J.EJHEART.2005.05.001

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16084762

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46638446&oldid=2123613518"